Increased expression of wild-type p53 in response to DNA damage arrests cells late in the G1 stage of the cell cycle by stimulating the synthesis of inhibitors of cyclin-dependent kinases, such as p21/WAF1. To study the effects of p53 without the complication of DNA damage, we used tetracycline to regulate its expression in MDAH041 human fibroblasts that lack endogenous p53. When p53 is expressed at a level comparable to that induced by DNA damage in other cells, most MDAH041 cells arrested in G1, but a significant fraction also arrested in G2/M. Cells released from a mimosine block early in S phase stopped predominantly in G2/M in the presence of p53, confirming that p53 can mediate arrest at this stage, as well as in G1. In these cells, there was appreciable induction of p21/WAF1. MDAH041 cells arrested by tetracycline-regulated p53 for as long as 20 days resumed growth when the p53 level was lowered, in striking contrast to the irreversible arrest mediated by DNA damage. Therefore, irreversible arrest must involve processes other than or in addition to the interaction of p53-induced p21/WAF1 with G1 and G2 cyclin-dependent kinases.
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The tumor suppressor gene p53 is important in the etiology of cancer and is mutated, deleted, or rearranged in more than half of all human tumors (1, 2) . p53 mediates either apoptosis or cell cycle arrest in response to DNA damage, thus acting as a molecular "guardian of the genome" (3). Kastan et al. (4) reported that human ML-1 leukemia cells exposed to ionizing radiation are transiently arrested in G1, supporting the idea that p53-dependent G1 arrest following DNA damage allows cells time to repair the damage. In contrast, the more recent experiments of Di Leonardo et al. (5) with primary human fibroblasts have shown that, although radiation treatment does induce G1 arrest, the arrest is irreversible, leading the authors to suggest that it is more important to stop cells containing damaged DNA from proliferating than to facilitate repair of their damaged DNA in advance of S phase. The basis for the different responses of these two different types of cells is not clear but may be related to the observation that lymphocytes usually undergo apoptosis in response to DNA damage, whereas normal fibroblasts do not show this response (6) .
The ability of p53 to arrest the cell cycle in rodent cells has been studied with a temperature-sensitive p53 protein (7) . When rat embryo fibroblast (REF) cells harboring this protein were grown at a permissive temperature, the protein acted like wild-type p53, and the cells did not enter S phase. Similarly, utilizing dexamethasone-regulated p53, Lin et al. (8) showed that human glioblastoma cells arrested mainly in late G1. p53
is a transcriptional activator of several genes, through which it can regulate events such as transformation and DNA synthesis (9) . An important target of p53 is p21/WAF1 (10, 11) , an inhibitor of most of the cyclin-dependent kinases (12) which help to regulate the cell cycle (13) . Since p21/WAF1 inhibits both the cyclin-dependent G1 kinases and the G2/M-specific cdc2 kinase, p53 may be capable of controlling both the G1 and the G2/M checkpoints. To investigate this possibility and to help clarify the role of p53 in transient or permanent cell cycle arrest, we have established a system for regulated expression of p53 without the need for DNA damage or a temperature shift, which may lead to unwanted complications. For this purpose, we used the tetracycline-regulated transactivator and operator plasmids developed by Gossen and Bujard (14) . Regulated expression of wild-type p53 in p53-null human fibroblasts causes growth arrest in both G1 and G2/M. The arrest is associated with high levels of p21/WAF1 and is reversible.
MATERIALS AND METHODS
The MDAH041 postcrisis cell line was derived from the fibroblasts of a patient with Li-Fraumeni syndrome (15) . There is a frameshift mutation of one p53 allele at codon 184 and the normal p53 allele has been lost (16) . The cells, kindly provided by M. Tainsky (17) , were grown in an atmosphere of 10% C02/90% air in Dulbecco's modified Eagle's medium, supplemented with 10% (vol/vol) fetal bovine serum. When employed, tetracycline (final concentration 1 jig/ml) was added directly to the medium. Plasmids pUHD 10-3, with the tetracycline operator; pUHD 151-1, with the tetracycline activator; and pUHC13-3, with a luciferase reporter gene, were kind gifts from H. Bujard (14) . Plasmid pHSG-p53wt, containing wild-type human p53 cDNA, was the kind gift of Peter Chumakov (Engelhardt Institute, Moscow). For cell cycle experiments, trypsinized cells were stained with propidium iodide by using the Cycletest kit (Becton Dickinson) and analyzed for DNA content by using the FACScan (Becton Dickinson). Cell cycle distribution was determined using CELL Frr Software (HP340 Series 9000 Workstation). Dead cells were gated out by using pulse processing. In some experiments, the cells were treated with 200 ,uM mimosine (Sigma) for 48 h to synchronize them in early S phase (18 Proc. Natl. Acad. Sci. USA 92 (1995) ,uM BrdUrd for 2 h and fixed in methanol/acetic acid/water (90:5:5, vol/vol) for 30 min. The incorporation of BrdUrd into DNA was determined by immunostaining by using antibodies directed against BrdUrd (Amersham).
RESULTS
Regulated Expression of p53. To achieve tetracyclineregulated expression, human wild-type p53 cDNA was inserted into pUHD 10-3 (14) , together with a neomycin-resistance gene, to yield pTO.p53.neo (Fig. 1) . A sequence providing hygromycin resistance was inserted into pUHD 151-1 (14) , which carries the tetracycline-responsive transactivator, to yield pTA.hygro (Fig. 1) .
In the p53-null fibroblast cell line MDAH041, no p53 protein could be detected by Western blot analysis using the DO-1 antibody, which recognizes both wild-type and mutant proteins (data not shown). However, MDAH041 cells behave very much like normal cells when functional p53 is restored under control of the normal p53 promoter, suggesting that most or all downstream functions are intact. For example, these cells do not yield resistant colonies upon selection with N-(phosphonacetyl)-L-aspartate (PALA), in contrast with parental MDAH041 cells, which do yield such colonies readily (M.L.A., A.A., and G.R.S., unpublished data). This phenotype depends on a normal p53 pathway (16, 20) .
MDAH041 cells were transfected with pTA.hygro, which contains the tetracycline-regulated transactivator ( Fig. 1) . Several hygromycin-resistant, stable clones were analyzed by transfecting them transiently with pTO.luc, which contains a luciferase reporter gene driven by the cis-acting element recognized by the tetracycline-regulated transactivator. The clone chosen for further use showed a 13-fold increase in luciferase activity after withdrawal of tetracycline. After transfection with pTO.p53.neo, several derivative clones resistant to both neomycin and hygromycin were isolated and cultured in the presence of tetracycline. A representative clone, TR9-7, which arrested after withdrawal of tetracycline for 3-4 days, was used for all subsequent experiments. When TR9-7 cells are grown in the presence of 1 jig of tetracycline per ml, p53
protein is expressed at a very low level, which is insufficient to induce p21/WAF1 or cell cycle arrest ( Fig. 2A) . Decreasing the concentration of tetracycline leads to an incremental increase in both p53 protein and function, as determined by induction of p21/WAF1 (Fig. 2A) 16-20 h (Fig. 2B) . The p53 protein remains at a high level as long as tetracycline is absent.
p53-Mediated Reversible Growth Arrest in Human Cells.
To study the effects of p53 expression in a nearly normal human cell line without DNA damage, tetracycline was withdrawn from TR9-7 cells. Four days later, the cells had stopped growing and were enlarged and flattened compared with cells grown in the presence of tetracycline. By day 10, no rounded mitotic cells were observed (Fig. 3) of the arrest of DNA synthesis, TR9-7 cells were pulse-labeled with BrdUrd for 2 h at various times after removing tetracycline (Fig. 4) . The number of BrdUrd-positive cells decreased by as soon as 4 h, and by 72 h the majority of the cells did not incorporate BrdUrd. After 4 days, there was no BrdUrd incorporation ( Fig. 5 A and B) . Although the growth of TR9-7 cells ceased in the absence of tetracycline, the cells remained attached to the tissue-culture plates. When tetracycline was restored, the cells began to grow again, accompanied by incorporation of BrdUrd and a return of normal cell morphology (Fig. SC) . To measure the fraction of arrested TR9-7 cells that could resume growth upon removal of the p53 block, 500 dispersed cells were replated in the absence of tetracycline. After 5 days, tetracycline was restored, and colonies were counted 10 days later. The great majority of the cells (86%) were capable of forming colonies in this experiment. Cells arrested for up to 20 days in the absence of tetracycline were able to resume growth when tetracycline was restored.
p53 Controls Both G1 and G2/M Checkpoints. We determined cell-cycle distributions after withdrawing tetracycline from TR9-7 cells by FACScan analysis after staining with propidium iodide. There was a striking decrease in the number of cells in S phase after 48-72 h accompanied by an increase in the percentage of cells in both G1 and G2/M (Table 1) .
Similarly, analysis of the incorporation of BrdUrd after withdrawing tetracycline revealed a substantial decrease in DNA synthesis (Fig. 4) . The percentage of cells in S phase determined by BrdUrd incorporation was higher than that determined by analysis of DNA content. This difference may be due to the inclusion of very early and very late S-phase cells in the G1 and G2/M compartments when analyzing propidium iodide-stained nuclei.
To investigate further the induction of G2/M arrest by p53 in human fibroblasts in the absence of DNA damage, we synchronized the cells by treating them with 200 ,uM mimosine for 48 h, which arrests them reversibly at or near the start of S phase (18) (Fig. 6 A and B) . Mimosine was then withdrawn and half of the cells were incubated with or without tetracycline, respectively (Fig. 6C) . After 15 h, there was a considerable increase in the number of S-phase cells, in either the presence or absence of tetracycline. By 45 h, the cells with tetracycline (p53-minus) showed a nearly normal cell cycle distribution. However, those without tetracycline (p53-plus) showed a large increase in the number of cells in G2/M, which was still maintained after 72 h. Thus, when p53 is expressed without DNA damage after the G1/S checkpoint, the majority of cells arrest at the next available checkpoint, G2/M. The level of p53 expression in TR9-7 cells withdrawn from tetracycline is comparable with the level induced in HT1080 cells in response to DNA damage (Fig. 2C) , showing that the G2/M arrest is achieved at physiological levels of p53 protein.
p53-Mediated G2/M Arrest Is Associated with High Levels of p21/WAF1. Lysates of cells collected at various times after release from the mimosine block in the presence or absence of tetracycline were analyzed for levels of p53 and p21/WAF1 proteins (Fig. 7) . p53 is induced after withdrawal of tetracycline from cell released from the mimosine block. p21/WAF1 expression is induced with similar kinetics only in cells grown in the absence of tetracycline after release from the block and is maximal after 45 h.
DISCUSSION
The p53 tumor suppressor is a potent inhibitor of cellular proliferation. In previous studies, the temperature-sensitive mutant p53Vall35 was used to analyze how cells respond to high levels ofwild-type p53. REF cell lines transformed by activated human Ras and p53Val135 arrest in G1 and also in G2/M and S phase when shifted to a temperature at which the p53 protein is wild type (7). In contrast, a different study with similar cells showed that expression of wild-type p53 led to arrest in G1 only (21) . A more recent study has provided evidence that p53 does hinder G2/M progression in the rat cell line REF52 transfected with p53Vall35 (22) . Expression of wild-type p53 in a human ovarian cancer cell line by using p53Vall35 led to arrest in G2/M but not in G1 (23) . These apparently conflicting results might be explained if the point of cell cycle arrest effected by p53 were cell-type specific, were affected variably by the expression of dominant oncogenes, or were affected by mutations in other cell cycle control proteins.
To determine the effect of wild-type p53 on human fibroblasts with a normal phenotype and in the absence of DNA /G1  S  G2/M   0  59  28  13  3   59   25  16  12  61  22  17  20  61  21  18  40  69  10  21  48  70  7  23 damage, we used a well-controlled system to regulate p53 expression with tetracycline, which has little or no effect on mammalian cells (14) . Induction of p53 within a physiological range upon removal of tetracycline led to dramatic but reversible arrest. Cell cycle analysis after induction of p53 revealed a marked reduction in S phase and an increase in both G1-and G2/M, suggesting that p53 can regulate both the G2/M and G1/S transitions. To determine whether p53 can mediate efficient arrest of human fibroblasts in G2/M, we analyzed the effect of wild-type p53 in cells synchronized after the p53-dependent G1 checkpoint and found that p53 indeed does block the cycle efficiently in G2/M in the absence of DNA (lanes 7 and 8) .
damage. We also tested p53 function in cells arrested in G2/M and found high levels of p21/WAF1.
DNA damage induced by nitrogen mustard leads to arrest of Burkitt lymphoma cells in G2/M. These cells exhibit low levels of cdc2 activity, and it has been proposed that an inhibitor of the cdc25-catalyzed dephosphorylation of cdc2 is induced by DNA damage (24) . It is not known if this effect is p53 dependent. We find it intriguing that the G2/M arrest induced by p53 in the absence of DNA damage is associated with high levels of the cyclin-dependent kinase inhibitor p21/WAF1. There is also evidence that the G2/M arrest induced by DNA damage can occur independently of p53 (4), and we have observed significant accumulation in G2/M after treatment of p53-null MDAH041 fibroblasts with ionizing radiation (our unpublished data). Interestingly, recent studies have shown that p21/WAF1 can be induced by DNA damage through both p53-dependent and p53-independent mechanisms (25, 26 
